ID A5CKE2_HUMAN Unreviewed; 639 AA. AC A5CKE2; DT 12-JUN-2007, integrated into UniProtKB/TrEMBL. DT 12-JUN-2007, sequence version 1. DT 27-MAR-2024, entry version 110. DE SubName: Full=Platelet glycoprotein Ib alpha {ECO:0000313|EMBL:BAJ15421.1, ECO:0000313|EMBL:CAM97225.1}; DE Flags: Fragment; GN Name=GP1BA {ECO:0000313|EMBL:CAM97225.1}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606 {ECO:0000313|EMBL:CAM97225.1}; RN [1] {ECO:0000313|EMBL:CAM97225.1} RP NUCLEOTIDE SEQUENCE. RC STRAIN=170743 {ECO:0000313|EMBL:CAM97225.1}; RA Witter K.; RT "An additional 39 bp repeat detected in the human platelet glycoprotein Ib RT alpha sequence."; RL Submitted (MAY-2007) to the EMBL/GenBank/DDBJ databases. RN [2] {ECO:0000313|EMBL:ACY72565.1} RP NUCLEOTIDE SEQUENCE. RA Xu L., Peng B., Yu S., Liu L., Zhang D., Sun G., Wang P., Sun N., Hu Q., RA Li X., Cao F.; RT "Single Novel Mutation in Transmembrane Region of Glycoprotein IX Affects RT Platelet Surface Expressions of Glycoprotein GP-Ib-IX Complex and Causes RT Bernard Soulier Syndrome."; RL Submitted (OCT-2009) to the EMBL/GenBank/DDBJ databases. RN [3] {ECO:0000313|EMBL:BAJ15421.1} RP NUCLEOTIDE SEQUENCE. RX PubMed=23414566; DOI=10.1016/j.thromres.2013.01.014; RA Yamamoto N., Akamatsu N., Sakuraba H., Matsuno K., Hosoya R., Nogami H., RA Kasahara K., Mitsuyama S., Arai M.; RT "Novel Bernard-Soulier syndrome variants caused by compound heterozygous RT mutations (case I) or a cytoplasmic tail truncation (case II) of GPIb?"; RL Thromb. Res. 131:e160-e167(2013). CC -!- INTERACTION: CC A5CKE2; P0DTC2: S; Xeno; NbExp=3; IntAct=EBI-28956381, EBI-25474821; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; GU133003; ACY72565.1; -; Genomic_DNA. DR EMBL; AB576655; BAJ15421.1; -; Genomic_DNA. DR EMBL; AM709890; CAM97225.1; -; Genomic_DNA. DR AlphaFoldDB; A5CKE2; -. DR IntAct; A5CKE2; 1. DR PeptideAtlas; A5CKE2; -. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-KW. DR Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1. DR InterPro; IPR000483; Cys-rich_flank_reg_C. DR InterPro; IPR001611; Leu-rich_rpt. DR InterPro; IPR003591; Leu-rich_rpt_typical-subtyp. DR InterPro; IPR032675; LRR_dom_sf. DR InterPro; IPR000372; LRRNT. DR PANTHER; PTHR46473:SF21; ELRR (EXTRACELLULAR LEUCINE-RICH REPEAT) ONLY; 1. DR PANTHER; PTHR46473; GH08155P; 1. DR Pfam; PF13855; LRR_8; 1. DR Pfam; PF01462; LRRNT; 1. DR PRINTS; PR00019; LEURICHRPT. DR SMART; SM00364; LRR_BAC; 4. DR SMART; SM00369; LRR_TYP; 5. DR SMART; SM00082; LRRCT; 1. DR SMART; SM00013; LRRNT; 1. DR SUPFAM; SSF52058; L domain-like; 1. DR PROSITE; PS51450; LRR; 2. PE 1: Evidence at protein level; KW Leucine-rich repeat {ECO:0000256|ARBA:ARBA00022614}; KW Membrane {ECO:0000256|SAM:Phobius}; Repeat {ECO:0000256|ARBA:ARBA00022737}; KW Signal {ECO:0000256|ARBA:ARBA00022729, ECO:0000256|SAM:SignalP}; KW Transmembrane {ECO:0000256|SAM:Phobius}; KW Transmembrane helix {ECO:0000256|SAM:Phobius}. FT SIGNAL 1..16 FT /evidence="ECO:0000256|SAM:SignalP" FT CHAIN 17..639 FT /evidence="ECO:0000256|SAM:SignalP" FT /id="PRO_5010103128" FT TRANSMEM 518..542 FT /note="Helical" FT /evidence="ECO:0000256|SAM:Phobius" FT DOMAIN 19..51 FT /note="LRRNT" FT /evidence="ECO:0000259|SMART:SM00013" FT DOMAIN 221..281 FT /note="LRRCT" FT /evidence="ECO:0000259|SMART:SM00082" FT REGION 336..446 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 336..385 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 386..444 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT NON_TER 639 FT /evidence="ECO:0000313|EMBL:CAM97225.1" SQ SEQUENCE 639 AA; 70248 MW; 387BFD59BE431A60 CRC64; MPLLLLLLLL PSPLHPHPIC EVSKVASHLE VNCDKRNLTA LPPDLPKDTT ILHLSENLLY TFSLATLMPY TRLTQLNLDR CELTKLQVDG TLPVLGTLDL SHNQLQSLPL LGQTLPALTV LDVSFNRLTS LPLGALRGLG ELQELYLKGN ELKTLPPGLL TPTPKLEKLS LANNNLTELP AGLLNGLENL DTLLLQENSL YTIPKGFFGS HLLPFAFLHG NPWLCNCEIL YFRRWLQDNA ENVYVWKQGV DVKAMTSNVA SVQCDNSDKF PVYKYPGKGC PTLGDEGDTD LYDYYPEEDT EGDKVRATRT VVKFPTKAHT TPWGLFYSWS TASLDSQMPS SLHPTQESTK EQTTFPPRWT PNFTLHMESI TFSKTPKSTT EPTPSPTTSE PVPEPAPNMT TLEPTPSPTT PEPTSEPAPS PTTPEPTSEP APSPTTPEPT PIPTIATSPT ILVSATSLIT PKSTFLTTTK PVSLLESTKK TIPELDQPPK LRGVLQGHLE SSRNDPFLHP DFCCLLPLGF YVLGLFWLLF ASVVLILLLS WVGHVKPQAL DSGQGAALTT ATQTTHLELQ RGRQVTVPRA WLLFLRGSLP TFRSSLFLWV RPNGRVGPLV AGRRPSALSQ GRGQDLLSTV SIRYSGHSL //